Shock Pleuropulmonary

Pleuropulmonary Shock: Understanding and Treatment

Introduction:

Pleuropulmonary shock is a traumatic shock that occurs when the chest and organs of the chest cavity, including internal organs, are damaged due to excessive irritation of the receptors of the visceral and parietal pleura. This type of shock can be caused by trauma to the chest, including during surgery. In this article we will consider the main aspects of pleuropulmonary shock, its mechanisms of development, clinical manifestations and treatment.

Development mechanisms:

Pleuropulmonary shock is associated with irritation of pleural receptors, which are located both on the inner surface of the chest (parietal pleura) and on the surface of the lungs (visceral pleura). When there is injury to the chest cavity, such as a rib fracture, pneumothorax, or chest trauma, these receptors become overstimulated.

Irritation of pleural receptors leads to activation of the sympathetic nervous system and the release of inflammatory mediators such as histamine, bradykinin and prostaglandins. This leads to vasodilation, increased vascular permeability and an increase in the volume of plasma passing into the intercellular space. In addition, a spasm of the smooth muscles of the bronchi occurs, which leads to deterioration of ventilation. As a result of these changes, hypovolemia, hypoxia and impaired gas exchange develop.

Clinical manifestations:

Patients with pleuropulmonary shock often present with symptoms of hypovolemia, including decreased blood pressure, tachycardia, pale skin, chills, and sweating. Hypoxia may manifest as shortness of breath, cyanosis (blue color), and changes in oxygen saturation in the blood. Patients may also experience chest pain, which may be due to trauma or spasm of bronchial smooth muscle.

Diagnosis and treatment:

Diagnosis of pleuropulmonary shock includes a clinical examination, assessment of vital signs (including blood pressure, pulse, respiratory rate, and oxygen saturation), and additional tests such as a chest X-ray or CT scan to detect injury or other abnormal changes.

Treatment of pleuropulmonary shock includes stabilization of the patient and immediate measures to restore circulating blood volume. This may include intravenous fluids and, if necessary, blood or blood products. Oxygen therapy is also an important aspect of treatment to ensure adequate oxygen supply.

Additional measures include controlling pain, bronchospasm, and preventing complications. Analgesics can be used to control pain, and bronchodilators can be used to relieve bronchospasm. If there is significant damage to the chest cavity or organs, surgery may be required to repair the damage.

The prognosis of patients with pleuropulmonary shock depends on the severity of the injuries and the timeliness of medical care. If diagnosed early and treated adequately, many patients can make a full recovery. However, if injuries are severe or treatment is delayed, serious complications such as acute respiratory failure, infection, or even death can occur.

Conclusion:

Pleuropulmonary shock is a serious condition that occurs when the chest and chest organs are damaged. Early identification and treatment of this condition plays a critical role in the patient's prognosis. Medical care must be prompt and include stabilizing the patient, restoring blood volume, ensuring adequate oxygen supply, and preventing complications. It is important to remember that pleuropulmonary shock requires a comprehensive approach to treatment and close collaboration between multiple medical specialists to achieve the best outcome and patient survival.

Pleuropulmonary shock

**Pleuropulmonary shock (PPS)** is a traumatic shock that occurs when the chest organs are damaged due to excessive irritation of pleural receptors. In this article we will consider the features of this pathology, the causes of its occurrence, as well as possible methods